Brain Cancer Trial, Recruiting NCT06164314 Sponsor: Beijing Tiantan Hospital Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT06164314
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have a brain tumour (glioma) located in the temporal region of the brain and are scheduled for planned brain surgery
  • You are 18 years of age or older
  • You are willing and able to give written consent to take part in the trial

Who may not be able to join:

  • You have serious problems with memory or thinking ability before the surgery
  • You have had a significant head injury or any previous brain surgery
  • You have a history of taking medications that affect mood, behaviour, or mental health (such as antidepressants or antipsychotics) (confirm with trial site)
  • You have a known allergy to the medication dexmedetomidine
  • You are currently pregnant or breastfeeding
  • You have a history of obstructive sleep apnoea (a condition where breathing repeatedly stops during sleep)
  • You have a very slow heart rate (fewer than 40 beats per minute), a specific heart rhythm problem called sick sinus syndrome, or a significant problem with the electrical signals in your heart (second- or third-degree heart block) (confirm with trial site)
  • You have serious liver problems
  • You have serious kidney problems

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yuming Peng, Beijing Tiantan Hospital

Phone: 0086+18601076588

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Tiantan Hospital
Registry
ClinicalTrials.gov
Start date
25 January 2024
Est. completion
30 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

the incidence of delirium postoperatively

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov